Dordaviprone

Dordaviprone, sold under the brand name Modeyso, is an anti-cancer medication used for the treatment of diffuse midline glioma (a type of brain tumor).Dordaviprone is a protease activator of the mitochondrial caseinolytic protease P.It is dopamine receptor D2 antagonist and an allosteric activator of the mitochondrial caseinolytic protease P.